Pharmaceutical company have contributed heavily to candidates, with 63 percent of their donations going to Democrats, Stat reports. And in other election-related news, KHN explains the "Medicare-for-all" buzz. Plus, how anti-vaccine supporters is backing candidates and a look at where the Georgia gubernatorial candidates stand on health issues.
from Kaiser Health News https://ift.tt/2zw59rm
November 06, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Youngest Students, Especially Boys, Are More Often Labeled With ADHD Diagnosis, Started On Drugs, Study FindsEven a couple months can make a big difference in a student's ability to focus in class, researchers found in the largest study looking at a strict Sept. 1 cutoff birth-date cutoff date for enrollment. Researchers studied ADH… Read More
A Look Inside Federal Prisons’ Failure To Treat Inmates With Mental-Health Illnesses Despite Policies Enacted To Do Just ThatThe Federal Bureau of Prisons updated its policy to better provide care for inmates with mental health disorders, but in practice didn't dole out any extra money to help those on the front lines of the crisis. Mental health w… Read More
Lawyers In Massive, Nation-Wide Opioid Case Want To Separate Suits Brought On Behalf Of Babies Born AddictedThe lawyers say the babies' specific needs have been lost in the sweeping case that is comprised of hundreds of local and state suits against companies who make opioids. The overall settlement is expected to rival the $240 bi… Read More
‘Deeply Disturbed’ Scientists Call For Halt To Practice Of Gene-Editing Embryos, But Don’t Rule Out Future PossibilitiesAmid a fiery outcry from the scientific community, He Jiankui's gene-editing project has been suspended amid a Chinese government investigation. But scientists are not closing the door on the practice entirely. Instead they s… Read More
Not Only Are Once-A-Day Pills For Combating HIV Less Expensive Than Other Regimens, Patients Are More Likely To Take ThemAn analysis found that on average, health plans would save $4,162 per patient each year if they switched to clinically equivalent single-tablet regimens. Meanwhile, a coalition of conservative groups is asking President Donal… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment